PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.\', \'Immunonclogical COoperative Group (ICOG) of the Comprehensive Cancer Center Lower Saxoney, Hannover (CCC-N), Hannover, Germany.\', \'Genitourinary Oncology, Department of Urology, University Hospital Dresden, Dresden, Germany.\', \'Department of Urology, University Medicine Greifswald, Greifswald, Germany.\', \'Urologie-Altstadtquartier Magdeburg, Magdeburg, Germany.\', \'Department of Radiation Oncology, West German Cancer Center, University Hospital Essen of the University Duisburg-Essen, Essen, Germany.\', \'Urology and Urooncology Practice Berlin, Vice Chairman d-uo (Deutsche Uro-Onkologen), Berlin, Germany.\', \'Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tübingen, Germany. jens.bedke@med.uni-tuebingen.de.\', \'Interdisciplinary Genitourinary Oncology, West-German Cancer Center Essen Clinic for Medical Oncology and Clinic for Urology OZ1, University Hospital Essen (AöR), Room 2.073 Hufelandstraße 55, 45147, Essen, Germany. viktor.gruenwald@uk-essen.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00432-020-03341-4
?:hasPublicationType
?:journal
  • Journal of cancer research and clinical oncology
is ?:pmid of
?:pmid
?:pmid
  • 32816108
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.235
?:rankingScore_hIndex
  • 84
?:title
  • Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N).
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all